Literature DB >> 2826571

Fibrolamellar cancer of the liver.

H J Hodgson1.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2826571     DOI： 10.1016/s0168-8278(87)80580-9

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

1.  CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.

Authors:  Lars H Engelholm; Anjum Riaz; Denise Serra; Frederik Dagnæs-Hansen; Jens V Johansen; Eric Santoni-Rugiu; Steen H Hansen; Francesco Niola; Morten Frödin
Journal:  Gastroenterology       Date:  2017-09-18       Impact factor: 22.682

2.  Late supra-diaphragmatic lymph node recurrence following resection of a fibrolamellar hepatocarcinoma: an unusual case.

Authors:  Basile Tsilividis; Emmanuel Huet; Jean Lubrano; Laurence Lacaze; Jean Pierre Lestrat; Arnaud François; Ghassan Riachi; Michel Scotté
Journal:  Surg Radiol Anat       Date:  2009-09-24       Impact factor: 1.246

3.  Clinicopathological features and surgical outcome of patients with fibrolamellar hepatocellular carcinoma (experience with 22 patients over a 15-year period).

Authors:  Mohamed Abdel Wahab; Ehab El Hanafy; Ayman El Nakeeb; Mahmoud Abdelwahab Ali
Journal:  World J Gastrointest Surg       Date:  2017-02-27

4.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.